Consort Medical (CSRT)

Sector:

Health Care

Index:

FTSE Small Cap

756.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 1,210.00
  • 52 Week Low: 700.00
  • Currency: UK Pounds
  • Shares Issued: 49.36m
  • Volume: 1,054
  • Market Cap: £373.19m
  • Beta: 0.09

Consort Medical Overview

Consort Medical is in the health care sector and is currently trading at 756.00p per share. In the last year Consort Medical's share price has ranged from 700.00p to 1,210.00p and brokers are currently rating this stock as 'buy'.
Competitors: Convatec Group , Advanced Medical Solutions, Akers Biosciences, Inc.
Registrars: Capita Registrars

Key Personnel

CEO: Jonathan Glenn
CFO & Executive Director: Paul Hayes
Chairman: Chris Brinsmead
Senior Independent Non-Executive Director: William Jenkins
Non-Executive Dir: Andrew Hosty, Charlotta Ginman-Jones, Steve Crummett, Ian James Nicholson

Contact Details

Address: Breakspear Park Breakspear Way Hemel Hempstead Hertfordshire,United Kingdom, HP2 4TZ
Phone: +44 (0)1442 867920
Fax: +44 (0)1442 245237
Website: http://www.consortmedical.com/

Listings

Sector: Health Care(LSE)
Index: techMARKFTSE Small CapFTSE All-ShareFTSE techMARK Focus
Overseas Listings: BATSLON:CSRTL
ISIN: GB0000946276

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Consort Medical Market Data

Currency UK Pounds
Share Price 756.00p
Change Today -2.00p
% Change -0.26 %
52 Week High 1,210.00
52 Week Low 700.00
Volume 1,054
Shares Issued 49.36m
Market Cap £373.19m
Beta 0.09

Consort Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.22% above the market average46.22% above the market average46.22% above the market average46.22% above the market average46.22% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
64.15% below the market average64.15% below the market average64.15% below the market average64.15% below the market average64.15% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Income
2.46% above the market average2.46% above the market average2.46% above the market average2.46% above the market average2.46% above the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Growth
76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average
88.24% below the sector average88.24% below the sector average88.24% below the sector average88.24% below the sector average88.24% below the sector average

What The Brokers Say

Strong Buy 5
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Consort Medical Dividends

  Latest Previous
  Final Interim
Ex-Div 19-Sep-19 17-Jan-19
Paid 25-Oct-19 15-Feb-19
Amount 13.80p 7.60p

Trades for 21-Oct-2019

Time Volume / Share Price
09:07 600 @ 756.00p
08:26 325 @ 758.04p
08:01 129 @ 758.86p

Consort Medical Key Personnel

CEO Jonathan Glenn
Chair Chris Brinsmead

Top of Page